of type I collagen was quantified with a radioimmunoassay for the cross linked carboxyterminal telopeptide of type I collagen (ICTP). Results-About 50% of the patients had increased S-ICTP and S-PIIINP values, whereas S-PINP was increased in only 20% of the patients. The mean SF:S ratios of these markers varied between 4 (for ICTP) and 340 (for PIIINP), indicating that markers of collagen metabolism are formed locally and then released into the circulation. SF-PINP and SF-PIIINP correlated with each other (r, = 0-86, p < 0-001) and with SF-ICTP (r, = 0.69, p < 0001, and r. = 0-65, p < 0001, respectively). SF-ICTP was clearly related to radiographic findings in the corresponding knee joint, patients with gross bone deformation having the greatest SF-ICTP concentrations. S-ICTP and S-PIIINP also correlated with conventional markers of disease activity, such as C reactive protein and joint swelling score. Conclusion-Markers of collagen metabolism both in serum and synovial fluid can be measured to provide an assessment of disease process in patients with RA. ICTP and PIIINP are the most informative. The disease process in patients with rheumatoid arthritis (RA) is usually assessed by so-called markers of disease activity, such as number of swollen joints, erythrocyte sedimentation rate (ESR) and concentration of C reactive protein (CRP) in 
Results
Centrifugation was found to decrease the levels of the markers of collagen metabolism in SF to the same extent as occurs with centrifugation of plasma to separate serum. With the exception of one sample each, the level of the markers after centrifugation, was decreased compared with native samples, by amounts varying from 6-3 to 11-7% for SF-ICTP and from 0-2 to 10-4% for SF-PIIINP. Table 1 shows the mean concentrations of the three markers of collagen metabolism in the sera ofthe patients with RA and in the controls. More than 50% of the patients had increased S-ICTP concentrations, and nearly 50°/0 had increased S-PIIINP; in contrast, only 19% of the patients had increased S-PINP concentrations. In all but one of the patients, the concentrations of individual markers were greater in SF than in serum. In the single exception having an S-ICTP value somewhat greater than the corresponding SF measurement, both concentrations were low. The median (SD, range) SF concentrations were ICTP 16-7 (18- Because the volume of a joint effusion can change rapidly, making the assessment of concentrations inappropriate, we also calculated the values as ratios of one compound to another, and obtained: 59-4 (95% CI 447-741) for SF-PINP:SF-ICTP, 95-1 (95% CI 742-116) for SF-PIIINP:SF-ICTP, and 1-9 (95% CI 1-6-2-3) for SF-PIlNP:SF-PINP. Table 2 shows the ratios of the markers in relation to the radiographic state (Larsen index) of the corresponding joint. Table 3 gives the correlations observed between the levels of the various markers of collagen metabolism in serum and synovial. fluid of patients. In serum, the closest correlation was between PIIINP and ICTP, and in synovial fluid it was that between PINP and PIIINP. In addition, the two markers of synthesis had clear correlations with SF-ICTP. A significant correlation was found also between the synovial fluid and serum concentrations of each of the individual markers.
In the controls, the following correlations were found between the serum concentrations of the markers of collagen metabolism: rs= 0-48, p < 0 001 for PINP v ICTP; rs=0-51, p<0001 for PIIINP v ICTP; r, = 034, p = O-OO1 for PINP v PIIINP. The balance of type I collagen metabolism, assessed by the ratio (mean (SD)) of S-PINP:S-ICTP, was in favour of degradation in patients compared with controls: 9 4 (5.4) and 12-1 (4 9), respectively (p < 0 00 1). Table 4 shows the correlations between indicators of disease activity and those of collagen metabolism. Both S-ICTP and S-PIIINP showed positive correlations with disease activity markers. None of the markers in SF correlated with the total number of leucocytes or with the number of polymorphonuclear leucocytes in SF.
Seven of the 39 female patients were premenopausal and 32 were postmenopausal. S-PINP values did not differ according to menopausal state, but increased S-ICTP and S-PIIINP concentrations were more common among the postmenopausal women, who more often had signs of active disease (increased CRP values and high joint swelling scores) that are known to be associated both with increased S-ICTP and S-PIIINP. S-ICTP and S-PIIINP values were significantly lower in patients currently receiving a DMARD compared with those not taking these drugs: mean values were 5-7 (3-9) ,ug/I v 8-6 (4 4) ,ug/l for S-ICTP (p = 0 010), and 4-7 (1.9) ,ug/l v 7-3 (3 9) ,ugll for S-PIIINP (p = 0021). The corresponding values for S-PINP were 44-5 (18-7) ,ugll v 61-5 (28-0) ,ug/l (p = 0 055). No significant differences in mean serum levels of the markers were found in patients taking or not taking peroral corticosteroids, but SF levels of all the markers were significantly greater in patients taking peroral corticosteroids compared with those not receiving this treatment. The explanation of this may be multifactorial, but patients treated with oral corticosteroids significantly more often had higher Larsen indexes in the knee under study than did those not taking these drugs. There was an association between the time elapsed since the last intra-articular injection of corticosteroids and SF-ICTP levels (p = 0007); patients receiving a recent intraarticular injection more often had lower levels of the marker.
Discussion
Markers of collagen synthesis and degradation measured in serum and synovial fluid reflect the grade of synovitis and tissue breakdown in RA. In this study we used assays for markers of the synthesis and degradation of type I collagen (PINP and ICTP) and for the synthesis of type III collagen (PIIINP). Type I collagen is the most abundant protein species in the human body. Most of it is present in bones, where it accounts for about 90% of the organic matrix, and it is also the major matrix protein in tendons, ligaments, and soft connective tissues. Type III collagen is the second most abundant collagen type and is found in soft connective tissues. High concentrations of all these collagen derived substances were found in synovial fluid, and their concentrations correlated with the grade of destruction in the joint. The high SF:S ratios, in particular for PIIINP and PINP, suggest that these antigens are formed locally in the inflamed joints and then released into the circulation. Jensen et al22 investigated the transport of PIIINP from the knee cavity into the circulation in conscious pigs after intraarticular injection of radiolabelled PIIINP. Sequential sampling of thoracic duct lymph, serum, and urine suggested that PIIINP is most probably transported from the joint space by bulk flow. Degradation in the lymphatics cannot be excluded completely, but a major part of PIIINP reaches the thoracic duct, and thereby the circulation, in the intact form.
In the present study, concentrations of S-PIIINP and S-ICTP were increased in about 50% of the patients, and also correlated with markers of disease activity such as CRP and the joint swelling score, these results being in accordance with earlier findings.9 10 13 23 In contrasi$,J-PINP was increased in only a minority the patients and did not correlate with disease activity. It is probable that, though PINP is released freely from the joints, the amount is small in comparison with that released from the skeleton. A shift in the balance of type I collagen metabolism in RA towards the direction of collagen breakdown was demonstrated by the decreased ratio S-PINP:S-ICTP in patients compared with control subjects. Similarly, a low rate of type I collagen synthesis, assessed by the carboxyterminal propeptide of type I procollagen (PICP) in serum, has been reported previously in RA. 24 SF-PINP and SF-PIIINP concentrations correlated strongly. The synthesis of both type I and type III collagen is obviously increased in the synovial tissue of a rheumatoid joint, from where the propeptides are released into SF. A high grade synovitis in a rheumatoid joint is usually accompanied by a destructive process in the joint. Accordingly, SF-PINP and SF-PIIINP showed a clear correlation with SF-ICTP. The assessment of synovial fluid constituents as concentrations is, however, somewhat inaccurate; there is a bidirectional fluid flux across the synovial lining,25 and the amount of effusion may vary rapidly. This is why we also compared the ratios between various markers with the radiographic findings in the joint. The ratios suggested more collagen synthesis in cases with less radiographic damage, and more collagen degradation in cases with more severe radiographic damage.
Radiographic images record past destructive activity in RA, while the markers of collagen metabolism in SF reflect the current balance between destructive and reparatory processes. SF-ICTP correlated most closely with the joint destruction. However, SF-ICTP showed a large variation in higher Larsen index groups, reflecting the varying activity of collagen degradation. It is evident that the markers of collagen metabolism, such as SF-ICTP or the ratio SF-PINP:SF-ICTP, provide information on the disease process in the joint additional to that obtained from radiographs alone.
In interpreting our results, certain confounding factors which might have influenced the results should be considered. Previous intra-articular injections are among the most important, and in our group there were some patients treated recently in this way. In addition, we found that serum levels of the markers of collagen metabolism were lower in patients currently taking DMARDs than in those not receiving these drugs. Our crosssectional study was not planned to investigate the effect of treatments on these markers. However, some longitudinal studies found that S-PIIINP and S-ICTP decrease more slowly than the acute phase reactants after commencement of DMARDs.'0 13 It should be noted also that biological variation in the serum level of these markers of collagen metabolism is about 20-25%, the least significant change for an individual being smaller than that for corresponding urinary markers (up to 50%).26 To be useful in the follow up of individual patients in clinical practice, the change in concentration of a marker in response to treatment should exceed the least significant change. Further longitudinal studies are required to clarify this question. As the markers of collagen metabolism are not tissue specific, it is not possible to trace their origin in synovial fluid. However, the results of the present study and of earlier reports 3 1516 suggest that PIIINP and PINP are synthesised in synovial tissue. A strong correlation between these two propeptides and their stable ratio regardless of the degree of radiological damage in the knee joint suggest that most of the SF-PINP is derived from synovial tissue, and only a small part from the articular bone. SF-ICTP, a breakdown product of type I collagen, may reflect the degradation of this collagen in synovial tissue, joint capsule, and ligaments, while necrotic areas may be found in active synovitis, sometimes shown as 'rice bodies' in synovial fluid. However, type I collagen is most abundant in mineralised bone, and in our patients with the highest Larsen index scores of the knee joint, indicating destructive disease, and with high SF-ICTP levels, most of the ICTP was most probably derived from articular bone.
